Camber Capital Management’s Medtronic MDT Stock Holding History

Camber Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,750,000	Closed	-$220M	–	37
2024 Q4	$220M	Hold	2,750,000	–	–	5.08%	2
2024 Q3	$248M	Buy	2,750,000 +500,000	+22%	+$42.1M	7.86%	3
2024 Q2	$177M	Buy	2,250,000 +400,000	+22%	+$32.8M	4.9%	4
2024 Q1	$161M	Hold	1,850,000	–	–	3.95%	9
2023 Q4	$152M	Buy	1,850,000 +350,000	+23%	+$26.7M	3.88%	8
2023 Q3	$118M	Buy	1,500,000 +900,000	+150%	+$75.3M	3.87%	7
2023 Q2	$52.9M	Buy	+600,000	New	+$51.7M	1.72%	20
2022 Q4	–	Sell	-500,000	Closed	-$40.4M	–	44
2022 Q3	$40.4M	Buy	+500,000	New	+$44.9M	1.24%	27
2022 Q2	–	Sell	-500,000	Closed	-$55.5M	–	43
2022 Q1	$55.5M	Buy	+500,000	New	+$52.8M	2.01%	19

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Camber Capital Management's MDT Position: Q1 2025 in Review

Camber Capital Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 2,750,000 shares — an estimated $220M sold.

Camber Capital Management first reported a position in MDT in Q1 2022 and held it in 9 quarters. The position peaked at $248M in Q3 2024. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

Camber Capital Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
Camber Capital Management sold 2,750,000 Medtronic shares in Q1 2025, an estimated $220M.
Camber Capital Management first reported a position in Medtronic in Q1 2022 and held it in 9 quarters.
Camber Capital Management's Medtronic position peaked at $248M in Q3 2024.
2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Camber Capital Management's 13F filing for Q1 2025, filed 15 May 2025.